Skip to content
Strategic Partnering
News
Contact Us
Strategic Partnering
News
Contact Us
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
Strategic Partnering
News
Contact Us
About Us
Our Mission
Leadership
Grants
Disease Areas
Topical Scarring & Burns
Organ Fibrosis
Autoimmune Disorders
Wrinkles & Rhytids
Our Science
FS2: Kynurenic Acid
AI-001: Antigen-Presenting Cells
University of British Columbia
Products & Pipeline
NHP / Cosmetics Platform
Clinical Program & Pipeline
Strategic Partnering
News
Contact Us
BirchBioMed Receives Health Canada Approval for Topical Cream (NPN 80147114)
02-04-26_NNHPD Licence Approval-Final 42
